Transcription and/or DNA methylome signatures were found to be associated with response to different anti-TNF therapy in peripheral blood mononuclear cells (PBMCs), monocytes, and CD4+ T cells from RA patients (403). The gene discussed is CD4; the disease is rheumatoid arthritis.